These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 15364012)
1. Carbamazepine enhances brain production of kynurenic acid in vitro. Kocki T; Kocki J; Wielosz M; Turski WA; Urbanska EM Eur J Pharmacol; 2004 Sep; 498(1-3):325-6. PubMed ID: 15364012 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of brain kynurenic acid production by anticonvulsants--novel mechanism of antiepileptic activity? Kocki T; Wielosz M; Turski WA; Urbanska EM Eur J Pharmacol; 2006 Jul; 541(3):147-51. PubMed ID: 16765940 [TBL] [Abstract][Full Text] [Related]
3. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid. Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380 [TBL] [Abstract][Full Text] [Related]
4. SNAP and SIN-1 increase brain production of kynurenic acid. Luchowski P; Urbanska EM Eur J Pharmacol; 2007 Jun; 563(1-3):130-3. PubMed ID: 17391664 [TBL] [Abstract][Full Text] [Related]
5. Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain--in vitro and ex vivo evidence. Zielińska E; Kuc D; Zgrajka W; Turski WA; Dekundy A Toxicol Appl Pharmacol; 2009 Oct; 240(2):174-9. PubMed ID: 19616570 [TBL] [Abstract][Full Text] [Related]
6. The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of L-kynurenine to kynurenic acid: an in vitro study. Rozsa E; Robotka H; Nagy D; Farkas T; Sas K; Vecsei L; Toldi J Brain Res Bull; 2008 Jul; 76(5):474-9. PubMed ID: 18534254 [TBL] [Abstract][Full Text] [Related]
7. Kynurenic acid synthesis in cerebral cortical slices of rats with progressing symptoms of thioacetamide-induced hepatic encephalopathy. Saran T; Hilgier W; Urbańska EM; Turski WA; Albrecht J J Neurosci Res; 2004 Feb; 75(3):436-40. PubMed ID: 14743457 [TBL] [Abstract][Full Text] [Related]
8. Effect of pesticides on kynurenic acid production in rat brain slices. Zielińska E; Kocki T; Saran T; Borbely S; Kuc D; Vilagi I; Urbańska EM; Turski WA Ann Agric Environ Med; 2005; 12(2):177-9. PubMed ID: 16457470 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors modulate kynurenic acid production in rat brain cortex in vitro. Zakrocka I; Turski WA; Kocki T Eur J Pharmacol; 2016 Oct; 789():308-312. PubMed ID: 27423316 [TBL] [Abstract][Full Text] [Related]
10. Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in cultured cerebral cortical neurons. Rzeski W; Kocki T; Dybel A; Wejksza K; Zdzisińska B; Kandefer-Szerszeń M; Turski WA; Okuno E; Albrecht J J Neurosci Res; 2005 Jun; 80(5):677-82. PubMed ID: 15880762 [TBL] [Abstract][Full Text] [Related]
11. Cerebrolysin lowers kynurenic acid formation--an in vitro study. Baran H; Kepplinger B Eur Neuropsychopharmacol; 2009 Mar; 19(3):161-8. PubMed ID: 19008081 [TBL] [Abstract][Full Text] [Related]
12. 1-Methyl-4-phenylpyridinium and 3-nitropropionic acid diminish cortical synthesis of kynurenic acid via interference with kynurenine aminotransferases in rats. Luchowski P; Luchowska E; Turski WA; Urbanska EM Neurosci Lett; 2002 Sep; 330(1):49-52. PubMed ID: 12213632 [TBL] [Abstract][Full Text] [Related]
13. N(G)-nitro-L-arginine and its methyl ester inhibit brain synthesis of kynurenic acid possibly via nitric oxide-independent mechanism. Luchowski P; Kocki T; Urbańska EM Pol J Pharmacol; 2001; 53(6):597-604. PubMed ID: 11985333 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain. Guidetti P; Amori L; Sapko MT; Okuno E; Schwarcz R J Neurochem; 2007 Jul; 102(1):103-11. PubMed ID: 17442055 [TBL] [Abstract][Full Text] [Related]
15. D-Cycloserine lowers kynurenic acid formation--new mechanism of action. Baran H; Kepplinger B Eur Neuropsychopharmacol; 2014 Apr; 24(4):639-44. PubMed ID: 24189377 [TBL] [Abstract][Full Text] [Related]
16. Clenbuterol enhances the production of kynurenic acid in brain cortical slices and glial cultures. Luchowska E; Kloc R; Wnuk S; Olajossy B; Wielosz M; Urbańska EM Pharmacol Rep; 2008; 60(4):574-7. PubMed ID: 18799828 [TBL] [Abstract][Full Text] [Related]
17. L-cysteine sulphinate, endogenous sulphur-containing amino acid, inhibits rat brain kynurenic acid production via selective interference with kynurenine aminotransferase II. Kocki T; Luchowski P; Luchowska E; Wielosz M; Turski WA; Urbanska EM Neurosci Lett; 2003 Jul; 346(1-2):97-100. PubMed ID: 12850557 [TBL] [Abstract][Full Text] [Related]
18. Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain. Vécsei L; Miller J; MacGarvey U; Beal MF Brain Res Bull; 1992 Feb; 28(2):233-8. PubMed ID: 1596743 [TBL] [Abstract][Full Text] [Related]
19. Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry. Guidetti P; Hoffman GE; Melendez-Ferro M; Albuquerque EX; Schwarcz R Glia; 2007 Jan; 55(1):78-92. PubMed ID: 17024659 [TBL] [Abstract][Full Text] [Related]
20. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice. Luszczki JJ; Mohamed M; Czuczwar SJ Eur J Pharmacol; 2006 Feb; 531(1-3):66-73. PubMed ID: 16403497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]